Imatinib Mesylate Reduces Voiding Frequency in Female Mice With Acute Cyclophosphamide-Induced Cystitis. [PDF]
Front Syst Neurosci, 2022 Perkins ME +3 more
europepmc +1 more source
A rare complication of imatinib mesylate therapy: drug-induced pneumonitis
Терапевтический архив, 2010 The use of imatinib mesylate (Glivec®) (Novartis Pharma AG, Switzerland) that is the drug of choice in treating patients with chronic myeloid leukemia (CML) has increased 7-year survival and improved the prognosis of the disease.
Ol'ga Veniaminovna Stakhina +7 more
doaj
Imatinib Mesylate Induces Necroptotic Cell Death and Impairs Autophagic Flux in Human Cardiac Progenitor Cells. [PDF]
Int J Mol Sci, 2022 Walmsley R +4 more
europepmc +1 more source
Modulation of Plasma 25-Hydroxyvitamin D3 Level by Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia: The Role of Uptake and Efflux Transporters. [PDF]
Curr Ther Res Clin Exp, 2022 Omran MM +5 more
europepmc +1 more source
Imatinib Mesylate-Loaded Rosin/Cinnamon Oil-Based In Situ Forming Gel against Colorectal Cancer Cells. [PDF]
Gels, 2022 Khaing EM +5 more
europepmc +1 more source
Imatinib Mesylate Reduces Neurotrophic Factors and pERK and pAKT Expression in Urinary Bladder of Female Mice With Cyclophosphamide-Induced Cystitis. [PDF]
Front Syst Neurosci, 2022 Perkins M +4 more
europepmc +1 more source
Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD. [PDF]
Cell Transplant, 2022 Baek DW +12 more
europepmc +1 more source
Cannabidiol modulates exosomal miRNA networks to enhance Imatinib mesylate response in chronic myelogenous leukemia. [PDF]
Glob Med GenetDonchev PP +3 more
europepmc +1 more source
Dynein axonemal heavy chain 9 M4374I variation may have an effect on imatinib mesylate resistance in CML. [PDF]
Med Int (Lond), 2022 Yildirim MS +4 more
europepmc +1 more source